NCT01477671

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children in India

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 667 (actual)
• Sponsor: Sanofi Pasteur, a Sanofi Company · Industry
• Sex: All
• Age: 5 Years – 10 Years
• Healthy volunteers: Accepted

Summary

This is a descriptive prospective community-based seroprevalence study. Primary objective: * To determine the prevalence of specific antibodies (immunoglobulin G \[IgG\]) against dengue in healthy 5 to 10 year-old children in India. Secondary objectives: * To determine the dengue virus serotype (DeNV-1,2,3 and /or 4) specific to the antibodies in positive (IgG) samples * To estimate the prevalence of specific antibodies (IgG) against Japanese encephalitis in healthy 5 to 10 year-old children in India.

Conditions

• Dengue
• Dengue Fever
• Dengue Hemorrhagic Fever

Timeline

• Start date: 2011-09-01
• Primary completion: 2012-09-01
• Completion: 2013-12-01
• First posted: 2011-11-22
• Last updated: 2018-01-11

Locations

4 sites across 1 country: India